Journals / Selçuk Tıp Dergisi / 2006 / Cilt: 22 - Sayı: 4

The relationship between age of onset, family history, extend of disease and prolactin levels of psoriasis patients

Psoriazisli hastalarda hastalığın başlangıç yaşı, aile öyküsü ve lezyon yaygınlığı arasındaki ilişki ve serum prolaktin düzeyleri

Pages
159–165
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: There was not a statisti­cally significant difference at serum prolactin levels when sex matched pairs of control and psoriasis group were compared.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The relationship between age of onset, family history, extent of disease and serum prolactin levels of psoriasis patients were investigated.
📊
Key Findings & Data:Material and method: Seventyfive psoriatic patients were enrolled for the study and 40 healthy volunteer were taken as control group.
💡
Conclusion & Impact:Conclusion: There was not a statisti­cally significant difference at serum prolactin levels when sex matched pairs of control and psoriasis group were compared.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Psoriyazis · Prolaktin · Aile özellikleri

Abstract

Aim: The relationship between age of onset, family history, extent of disease and serum prolactin levels of psoriasis patients were investigated. Material and method: Seventyfive psoriatic patients were enrolled for the study and 40 healthy volunteer were taken as control group. Age, sex and serum prolactin levels of the patients were recorded. The patients were questioned for family history and age of onset of psoriasis. The type, extent of psoriasis and whether the patient had artrit or not were recorded. Results: Twentytwo (29.3%) out of 75 patients with psoriasis, one patient (2.5%) in the control group had positive family history. When compared with non psoriatic patients, there was a statistically significant difference at the risk of seeing psoriasis in psoriatic patient's other family members. Forty nine (65.3%) out of 75 psoriatic patients had early onset, 26 (34.7%) had late on­set psoriasis. 21 (42.9%) of the patients with early onset psoriasis and 1 (3.8%) of the patients with late onset psoriasis had positive family histories. Fourteen (66.7%) out of 21 patients with early on­set familial psoriasis had extensive disease, whereas 7 (25.0%) out of 28 patients with early onset sporadic psoriasis had extensive disease. When compared with patients who had early onset spora­dic psoriasis, patients with early onset familial psoriasis had a higher risk of having extensive disease. High prolactin levels were detected only in 3 female patients in the psoriatic group. All of the pati­ents in the control group had normal serum prolactin levels. Conclusion: There was not a statisti­cally significant difference at serum prolactin levels when sex matched pairs of control and psoriasis group were compared.

Özet

Amaç: Psoriazisli hastalarda hastalığın başlangıç yaşı, aile öyküsü ve lezyon yaygınlığı arasındaki iliş­kinin ve serum prolaktin düzeylerinin araştırılması amaçlandı. Gereç ve yöntem: Yetmişbeş psori­azisli ve 40 kontrol olgusu çalışmaya alındı. Yaşları, cinsiyetleri, serum prolaktin düzeyleri kaydedildi. Hastalar, psoriazis başlangıç yaşı ve aile öyküsünde psoriazis bulunup bulunmadığı yönünden sor­gulandı. Psoriazisin formu, yaygınlık derecesi ve artrit bulunup bulunmadığı kaydedildi. Bulgular: Hastaların 22'sinde (% 29.3), kontrol grubunun Tinde (% 2.5) aile öyküsünde psoriazis vardı. Psoriazislilerin aile bireylerinde hastalığın görülme riskinde kontrol grubuna göre anlamlı fark vardı. Has­taların 49'unda (% 65.3) erken başlangıçlı, 26' sında (% 34.7) ise geç başlangıçlı psoriazis mevcut idi. Erken başlangıçlı olguların 21'nde (% 42.9), geç başlangıçların ise l'nde (% 3.8) aile öyküsü pozitif­ti. Erken başlangıçlı psoriazis ile birlikte aile öyküsü pozitifliği olan 21 hastadan 14'ünde (% 66.7) yay­gın seyir görülürken erken başlangıçlı psoriazisi olan ancak aile öyküsü olmayan 28 hastanın 7'sinde (% 25.0) yaygın seyir mevcut idi. Erken başlangıçlı psoriazisli hastalarda aile öyküsü varlığında, erken başlangıçlı ancak sporadik vakalara göre yaygın seyir görülmesi anlamlı şekilde fazlaydı. Psoriazisli 3 kadın hastada serum prolaktin düzeyi yüksek tespit edildi. Kontrol grubundakilerin prolaktin seviyele­ri normal sınırlarda idi. Sonuç: Hem erkek hem kadın hasta gruplarında prolaktin düzeylerinde ista­tistiksel olarak anlamlı bir fark saptanmadı.

🔖

Cite This Article

TAŞKENTLİ, L., ENGİN, B., MEVLİTOĞLU, İ. (2006). The relationship between age of onset, family history, extend of disease and prolactin levels of psoriasis patients. Selçuk Tıp Dergisi, Cilt: 22 - Sayı: 4, 159–165. https://ajindex.com/articles/319182

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Camp RDR. Psoriasis. Text book of Dermatology. 5 th edition, Volume 2. Champion RH, Burton JL, Ebling FJG (eds). Blackwell Scientific Publications, Oxford 1992; 1391-1457.
  2. Odom RB, James WD, Berger TG. Andrews' Dise­ases of the Skin. Clinical Dermatology. 9th edition. WB Saunders Company, Philadelphia 2000; 218-35.
  3. Giasuddin AS, El-Sharif Al, El-Ojali SI. Prolactin: do­es it have a role in the pathogenesis of psoriasis? Dermatology 1998; 197 (2): 119-22.
  4. Ferrandiz C, Pujol RM, Garcia-Patos V, Bordas X, Smandia JA. Psoriasis of early and late onset: A cli­nical and epidemiologic study from Spain. J Am Acad Dermatol 2002; 46(6): 867-73.
  5. Zhang X, Wang H, Te-shao Hsu, Yang S, Chen S. The genetic epidemiology of psoriasis in Chinese Han. Int J Dermatol 2002; 41: 663-69.
  6. Kundakci N, Türsen Ü, Babiker MO. The evaluati­on of the sociodemographic and clinical features of Turkish psoriasis patients. Int J Dermatol 2002; 41: 220-4.
  7. Christophers E, Mrowietz U. Psoriasis. Fitzpatrick's Dermatology in General Medicine. 5th edition, vo­lume 1. Eisen AZ, Wolf K, Austen KF, Goldsmith LA Katz SI,FitzpatrickTB(eds). Mc Graw-Hill, New York 1999; 495-521. Fry L Psoriasis. Br J Dermatol 1988; 119: 445-461
  8. Youn Jl, Park BS, Park SB, Kim SD, Suh DH. Charac­terization of early and late onset psoriasis in the Korean population. J Dermatol 1999 Oct; 26 (10): 647-52.
  9. Görgülü A, Akgün N.Psoriasiste familyal yansıma­lar. T Klin J Dermatol 1998;8:81 -3. Swanbeck G, inerot A, Martinsson T, Wahlstrom J, Enerback C, Enlund F, Yhr M. Age at onset and different types of psoriasis. Br J Dermatol 1995 Nov; 133 (5): 768-73.
  10. Stuart P, Malick F, Nair RP, Henseler T, Lim HW. Analysis of phenotypic variation in psoriasis as a function of age of onset and family history. Arch Dermatol Res 2002; 294: 207-13.
  11. University of Amsterdam, Department of Dermato­logy. The Netherlands. The pathomechanisms of psoriasis; the skin immune system and cyclospo­rin. Br J Dermatol 1988; 118:141-55.
  12. Hiestand PC, Mekler P, Nordmann R, Grieder A Permmongkol C. Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action for cyclosporine. Immuno­logy 1986; 83: 2599-603. Larson DF. Cyclosporin. Mechanism of action: an-toganism of the prolactin receptor. Prog Allergy 1986;38:222-38. Paus R. Does prolactin play a role in skin biology and pathology. Medical Hypotheses 1991; 36: 33-42.
  13. Dunna SF, Finlay AY. Psoriasis: improvement du­ring and worsening after pregnancy. Br J Derma­tol 1989; 120: